
Mind & Matter Peptides for Tissue Repair: BPC-157, TB-500 & the "Wolverine Stack"
Mar 22, 2026
Flynn McGuire, MD — a PM&R physician and researcher focused on neurologic recovery and musculoskeletal care. He discusses why peptides like BPC-157 and TB-500 rose in popularity. Short explanations of peptide biology, preclinical evidence for tissue repair, mechanisms like angiogenesis, stacking practices, major gaps in human trials, safety and sourcing risks.
AI Snips
Chapters
Transcript
Episode notes
BPC‑157 And TB‑500 Drive The Wolverine Hype
- Two peptides dominate musculoskeletal hype: BPC-157 (from gastric juice) and TB‑500 (fragment of thymosin beta‑4), often marketed together as the "Wolverine stack."
- Flynn notes these are the most visible items among many experimental peptides online.
BPC‑157 Acts Through Multiple Repair Pathways
- BPC‑157 is pleiotropic: it upregulates VEGF, affects nitric oxide pathways, reduces fibrosis, and may modulate neurotransmission.
- Flynn summarizes the likely mechanisms linking angiogenesis and fibroblast/collagen activity to faster repair in rodents.
Possible Neuromuscular Effects Are Plausible But Unclear
- BPC‑157 may stabilize neuromuscular junctions (acetylcholine receptors) and modulate dopamine/serotonin/GABA after injury, but CNS penetration is unclear.
- Flynn stresses stronger evidence exists for musculoskeletal than neural effects.
